BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20346592)

  • 1. Use of Acticoat dressings in burns: what is the evidence?
    Khundkar R; Malic C; Burge T
    Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
    Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
    Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
    Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
    Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study.
    Ryssel H; Germann G; Riedel K; Reichenberger M; Hellmich S; Kloeters O
    Ann Plast Surg; 2010 Oct; 65(4):391-5. PubMed ID: 20798627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
    Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
    J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acticoat dressings and major burns: systemic silver absorption.
    Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
    Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
    Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
    J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
    Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
    J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population.
    Cuttle L; Naidu S; Mill J; Hoskins W; Das K; Kimble RM
    Burns; 2007 Sep; 33(6):701-7. PubMed ID: 17644258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
    Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
    J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of Acticoat dressing in wound management.
    Dowsett C
    Br J Nurs; 2003 Oct; 12(19 Suppl):S44-9. PubMed ID: 14593271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing.
    Asz J; Asz D; Moushey R; Seigel J; Mallory SB; Foglia RP
    J Pediatr Surg; 2006 Dec; 41(12):e9-12. PubMed ID: 17161178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers.
    Miller AC; Rashid RM; Falzon L; Elamin EM; Zehtabchi S
    J Am Acad Dermatol; 2012 May; 66(5):e159-65. PubMed ID: 20724028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.
    Peters DA; Verchere C
    J Burn Care Res; 2006; 27(2):198-201. PubMed ID: 16566565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acticoat: a critique of application.
    Burd A; Chiu T; Huang L
    Burns; 2008 Jun; 34(4):575-7; author reply 578-9. PubMed ID: 18325677
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of silver nanoparticle dressing on second degree burn wound].
    Chen J; Han CM; Lin XW; Tang ZJ; Su SJ
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):50-2. PubMed ID: 16620649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquacel(®) Ag dressing versus Acticoat™ dressing in partial thickness burns: a prospective, randomized, controlled study in 100 patients. Part 1: burn wound healing.
    Verbelen J; Hoeksema H; Heyneman A; Pirayesh A; Monstrey S
    Burns; 2014 May; 40(3):416-27. PubMed ID: 24045072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.
    Fong J; Wood F; Fowler B
    Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.